Meet #OnKure’s new Senior Director of Clinical Operations, Amy Heim, and our new Senior Director Translational Medicine and Biomarkers, Brian Tunquist. Welcome to the #OnKure team!
You both are such great additions to the company!
Congratulations Amy Hughes Heim and Brian Tunquist!!!
We're excited to announce that OnKure has welcomed Sam Agresta, M.D., M.P.H., as Chief Medical Officer. Read more about Dr. Agresta and his new role here: https://lnkd.in/geNdVWaP
#OnKure is delighted to welcome Jessica Silver as Associate Director of Quality Assurance.
Today, #OnKure Therapeutics announced FDA IND clearance enabling Phase 1 initiation for OnKure's Mutant Selective PI3Ka inhibitor, OKI-219. Read more here: https://lnkd.in/gFhAdgA6
Last week #OnKure presented posters at the AACR-NCI-EORTC conference. The posters are available on OnKure’s website here: https://lnkd.in/eGaap3Vu
Today, #OnKure Therapeutics announced the appointment of Ann Howell, Pharm.D., as Vice President of Regulatory Affairs. Welcome to the team, Ann! Read more here: https://lnkd.in/d9bUSAP8.
Chief Scientific Officer at Vanqua Bio
1yGreat additions to a great team!